Why NeoGenomics (NEO) Stock Is Surging Today

Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.

Jul 7, 2014 3:12 PM EDT

NEW YORK (TheStreet) -- Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.

The stock was up 12.12% to $4.07 at 3:08 p.m. More than 1 million shares had changed hands, compared to the average volume of 270,889.

If you liked this article you might like

These have positive momentum and good growth.

Rev Shark

Jul 14, 2016 12:22 PM EDT

Keep accounts close to highs and don't give back gains.

Rev Shark

Jul 13, 2016 11:06 AM EDT

The merger closed in December, which means enough time is passed to evaluate whether the acquisition was positive or negative.

Robert Wasserman

Jul 6, 2016 10:38 AM EDT

It's unconcerned about rate hikes or the dollar.

James "Rev Shark" DePorre

May 27, 2016 4:18 PM EDT

Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.